FDA.reportPublic FDA data

Halaven 1 MG in 2 ML Injection

RxCUI
1045460
RxNorm name
Halaven 1 MG in 2 ML Injection
Display name
Halaven 1 MG in 2 ML Injection
Full name
Halaven 1 MG in 2 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:53

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
HalavenERIBULIN MESYLATEBSP Pharmaceuticals SpA8fc8fe1d-59fe-4e43-a95c-e7aa13422cd62026-01-26Exact identifier
rxcui: 1045460
HalavenERIBULIN MESYLATEEisai Inc.31ce4750-ded5-4a0b-95e9-f229fa6bc8222025-11-07Warnings, Adverse reactionsExact identifier
rxcui: 1045460

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
31ce4750-ded5-4a0b-95e9-f229fa6bc822Halaven 1 MG in 2 ML InjectionPSN69These highlights do not include all the information needed to use HALAVEN safely and effectively. See full prescribing information for HALAVEN. HALAVEN ® (eribulin mesylate) injection, for intravenous use Initial U.S. Approval: 201020251107
31ce4750-ded5-4a0b-95e9-f229fa6bc822Halaven 1 MG per 2 ML InjectionSY69These highlights do not include all the information needed to use HALAVEN safely and effectively. See full prescribing information for HALAVEN. HALAVEN ® (eribulin mesylate) injection, for intravenous use Initial U.S. Approval: 201020251107
31ce4750-ded5-4a0b-95e9-f229fa6bc8222 ML eribulin mesylate 0.5 MG/ML Injection [Halaven]SBD69These highlights do not include all the information needed to use HALAVEN safely and effectively. See full prescribing information for HALAVEN. HALAVEN ® (eribulin mesylate) injection, for intravenous use Initial U.S. Approval: 201020251107
31ce4750-ded5-4a0b-95e9-f229fa6bc8222 ML Halaven 0.5 MG/ML InjectionSY69These highlights do not include all the information needed to use HALAVEN safely and effectively. See full prescribing information for HALAVEN. HALAVEN ® (eribulin mesylate) injection, for intravenous use Initial U.S. Approval: 201020251107
8fc8fe1d-59fe-4e43-a95c-e7aa13422cd6Halaven 1 MG per 2 ML InjectionSY58HALAVEN ® (eribulin mesylate) injection 0.5 mg/mL20260126
8fc8fe1d-59fe-4e43-a95c-e7aa13422cd62 ML eribulin mesylate 0.5 MG/ML Injection [Halaven]SBD58HALAVEN ® (eribulin mesylate) injection 0.5 mg/mL20260126
8fc8fe1d-59fe-4e43-a95c-e7aa13422cd62 ML Halaven 0.5 MG/ML InjectionSY58HALAVEN ® (eribulin mesylate) injection 0.5 mg/mL20260126
8fc8fe1d-59fe-4e43-a95c-e7aa13422cd6Halaven 1 MG in 2 ML InjectionPSN58HALAVEN ® (eribulin mesylate) injection 0.5 mg/mL20260126